Table 1.
Enzyme | Alternative symbol | Observation | Disease setting | Cell type | Reference |
---|---|---|---|---|---|
DNMT1 | Decreased | SLE | WBCs | [10,12,13] | |
SLE | CD4+ T cells | [15] | |||
RA | |||||
DNMT3B | Decreased | SLE | WBCs | [10] | |
KAT2B | PCAF | Increased | SLE | PBMCs | [28] |
KAT3A | CBP | Decreased | SLE | CD4+ T cells | [27] |
KAT3B | P300 | Decreased | SLE | CD4+ T cells | [27] |
HDAC1 | Increased | SLE | PBMCs | [20] | |
FLSs | [21] | ||||
Decreased | FLS | Synovial tissues | [22] | ||
HDAC2 | Decreased | SLE | CD4+ T cells | [27] | |
HDAC4 | Altered sumoylation | RA | FLSs | [23] | |
HDAC7 | Decreased | SLE | CD4+ T cells | [27] | |
HDAC9 | Increased | SLE | CD4+ T cells | [24] | |
SIRT1 | Increased | SLE | CD4+ T cells | [27] | |
KMT? | SETD6 | Decreased | RA | PBMCs | [26] |
JIA | |||||
KMT1B | SUV39H2 | Decreased | SLE | CD4+ T cells | [27] |
KMT6 | EZH2 | Decreased | SLE | CD4+ T cells | [27] |
Increased | RA | FLSs | [25] | ||
KDM6B | JMJD3 | Decreased | SLE | CD4+ T cells | [29] |
CBP, CREB-binding protein; DNMT, DNA methyltransferase; EZH2, enhancer of Zeste, Drosophila, Homolog 2; FLS, fibroblast-like synoviocyte; HDAC, histone deacetylase; JIA, juvenile idiopathic arthritis; JMJD3, Jumonji domain-containing protein 3; KAT, K-acetyltransferase; KDM6B, lysine-specific demethylase 6B; KMT, K-methyltransferase; PBMC, peripheral blood mononuclear cell; PCAF, p300/CBP-associated factor; RA, rheumatoid arthritis; SETD6, SET domain containing 6; SIRT1, Sirtuin 1; SLE, systemic lupus erythematosus; SUV39H2, suppressor of variegation 3-9, Drosophila, Homolog of, 2; WBC, white blood cell.